跳至主要内容
临床试验/NCT05969834
NCT05969834已完成不适用

Human Chorionic Gonadotropin Levels After Ovulation Triggering as Predictors of Intracytoplasmic Sperm Injection Outcome

Mansoura University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年3月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
Clinical pregnancy rate

研究概览

简要总结

This study aimed to assess the correlation between HCG levels after ovulation triggering and ICSI outcomes, affected by HCG formulation and dose

详细描述

The aims of this study are:

  1. To assess the correlation between serum human chorionic gonadotropin (hCG) level after ovulation triggering and intracytoplasmic sperm injection (ICSI) outcome including: oocyte maturity and quality, good quality embryo rate, blastocyst formation rate and pregnancy rate
  2. To determine if there is an association between type and dose of the trigger and ICSI outcome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women who will undergo controlled ovarian stimulation (COS) through fixed GnRH antagonist protocol

排除标准

  • BMI > 30 kg/m2
  • Irregular menstruation
  • Severe male factor abnormality
  • Poor ovarian reserve
  • Endometriosis
  • Uterine abnormality

研究组 & 干预措施

uHCG group

Trigger intramuscular (IM) administration of 10000 IU of uHCG

干预措施: uHCG (Drug)

rHCG group

Trigger with subcutaneous (SC) administration of 6500 IU of rHCG

干预措施: rHCG (Drug)

Dual trigger group

Combined SC administration of 0.1 mg of GnRHa and IM administration of 2500 IU of uHCG

干预措施: uHCG and GnRHa (Drug)

结局指标

主要结局

Clinical pregnancy rate

时间窗: 6 weeks after embryo transfer

Number of clinical pregnancies (defined as presence of at least one intrauterine gestational sac with fetal pole and cardiac activity on TVS scan at 4-6 weeks after the ET) divided by the number of ET procedures

次要结局

  • Oocyte maturation rate(On 1 day of oocyte retrieval)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

HCG Levels After Ovulation Triggering as Predictors... | 临床试验